Continuous Glucose Monitoring After Kidney Transplant
Part of Hormones & metabolism clinical trials.
This study tests a small sensor called a continuous glucose monitor (CGM) that tracks your blood sugar after kidney transplant. It helps doctors see how your body handles sugar during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a kidney transplant.
- You are 18 years or older.
- You can use a small monitor on your skin for the first 10 days after surgery.
- You have no allergy to the sticky pads used with continuous glucose monitors.
- You have not had a combined kidney-liver or kidney-pancreas transplant.
- Your new kidney is still working well 48 hours after transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
This study tests if using a continuous glucose monitor (a sensor that checks your sugar levels all day) can improve blood sugar control in people with type 2 diabetes and kidney disease. You may join if your kidneys are at stage 3 or 4 (not on dialysis or transplant) and you take insulin.
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar levels in patients who have just received a liver transplant and have high blood sugar in the hospital.
This study uses a continuous glucose monitor (CGM) to watch for early signs that a transplanted pancreatic islet graft may be losing function. The goal is to catch problems sooner and help keep the transplant working well.
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
This study tests whether using a continuous glucose monitor (CGM) after leaving the hospital helps people with diabetes avoid being readmitted. If you have high blood sugar and need insulin at home, this device might help you manage better.
Hear when a new Hyperglycaemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.